Association of GSTM1 , GSTT1 Genes Polymorphisms and Risk of Psoriasis in Thi Qar Province / Iraq
Keywords:
Psoriasis, GSTs, polymorphism, PCRAbstract
Psoriasis is a ,chronic inflammatory, and proliferative skin disorder with a not entirely comprehended etiology. The aim of present study was to investigate the clinical features and estimate the association between null of GSTM1, GSTT1 genotypes and the development of psoriasis in Dhi Qar province. This study included 100 psoriasis patients and 100 healthy (mean age 29.08±16.46 and 31.8±11.2 respectively). Early onset was predominant (71%) than the late onset (mean of age onset 24.97±15.6). 51% of patients were males , 49% were females. Among cases 80% were non smoker, 20% were smoker. No significant between patient and control according to place of residence. Psoriasis vulgaris found in 65% of cases. Positive family history appear in 13% of patients. More of patients (56%) were exposure to stress during lifestyle. 5% patients were synchronized viral and bacterial infections. Analysis of GSTM1 , GSTT1 genotype showed no statistically significant with psoriasis susceptibility (OR=0.56; 95%, CI=0.32-0.99) and (OR=0.48; 95%, CI=0.25-0.92). Also the combined effect of GSTM1/GSTT1 null genotypes were found no increased risk of psoriasis (OR=0.55; 95%, CI=0.20-1.51).
References
Griffiths CE, Barker JN: Pathogenesis and clinical features of psoriasis. Lancet. 2007; 370: 263–271.
Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA, et al: Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008 ; 58: 826‑850.
Basko-Plluska JL, Petronic-Rosic V. Psoriasis: epidemiology, natural history, and differential diagnosis. Psoriasis: Targets and Therapy. 2012;2:67-76.
Elder J, Nair R, Guo S, Henseler T, Christophers E, Voorhees J. The genetics of psoriasis. Arch Dermatol. 1994;130:216–224.
Elder JT, Nair RP, Henseler T, et al. The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol. 2001;137:1447–1454.
Rahman PEJ. Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis. 2005;64 :37–39.
Kaur M, Sharma S, Kukreja S, Kaur J, Bassi R. Study of oxidative stress in patients of psoriasis. Int J Res Dermatol. 2016 ; 2:95-98.
Relhan V, Gupta SK, Dayal S, Pandey R, Lal H. Blood thiols and malondialdehyde levels in psoriasis. J Dermatol. 2002;29: 399–403.
Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases—what’s new? JEADV. 2003;17:663–9.
Cals-Grierson MM, Ormerod AD. Nitric oxide functions in the skin. Nitric Oxide. 2004;10(4):179–93.
Shindo Y, Witt E, Han D, Epstein W, Packer L. Enzymic and non-enzymic antoxidants in epidermis and dermis of human skin. J Investig Dermatol. 1994;102:122–4.
Langseth L. Oxidants, antioxidants and disease prevention. International Life Sciences Institute and ILSI Europe; 1995. p. 1–32.
Luty-Frackiwicz A, Gorka IM, Januszewska L. Influence of smoking and alcohol consumption on total antioxidant status in patients with psoriasis. Adv Clin Exp Med. 2006;15(3):463–9.
Baz K, Cimen MYB, Kokturk A, Yazici AC, Eskandari G, Ikizoglu G, et al. Oxidant/antioxidant status in patients with psoriasis. Yonsei Med J. 2003;44(6):987–90.
Van Haaften RI, Haenen GR, Evelo CT, Bast A. Effect of vitamin E on glutathione-dependent enzymes. Drug Metab Rev. 2003;35:215-53.
Katoh T, Yamano Y, Tsuji M, Watanabe M. Genetic polymorphisms of human cytosol glutathione S-transferases and prostate cancer. Pharmacogenomics. 2008;9:93-104
Norppa H .Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett. 2004; 149: 309–334.
Okcu MF, Selvan M, Wang LE, Stout L, Erana R, et al. Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res. 2004; 10: 2618–2625.
Daniel V. Glutathione S-transferases: gene structure and regulation of expression. Crit Rev Biochem Mol Biol .1993; 28: 173–207.
Jalood H, AL-Rikabi H, Al-Badran A and Kawen A. Glutathione S-Transferase (GSTM1, GSTT1) Genes Polymorphisms Associated with Vitiligo Disease in Thi Qar Province/South of Iraq. Int.J.Curr.Microbiol.App.Sci .2016; 5(8): 156-163.
Bassiouny, D.A. and Khorshied, M.M. Glutathione S-transferase M1 and T1 genetic polymorphisms in Egyption with nonsegmental vitiligo. Dermatol. 2013; 38(2): 160-163.
Abd Rabou, F., Elserogy, H., Gheida, S., EL-Ashmawy, A. Glutathione S-Transferase Gene Polymorphisms (GSTM1 and GSTT1) in Vitiligo Patients. Life Sci. J. 2011; 8(4): 785-792.
Zhang J, Deng J, Zhang C, et al. Association of GSTT1, GSTM1 and CYP1A1 polymorphisms with susceptibility to systemic lupus erythematosus in the Chinese population. Clin Chim Acta. 2010 ;411: 878–81.
Salimi S, Nakhaee A, Jafrri M, Jahantigh D, Sandooghi M, Zakeri Z,et al. Combination Effect of GSTM1, GSTT1 and GSTP1 Polymorphisms and Risk of Systemic Lupus Erythematosus. Iran J Public Health. 2015; 44 : 814-821.
Solak B, Karkucak M, Turan H , Ocakoğlu G, Sağ S, Yakut T, Erdem T. Glutathione S-Transferase M1 and T1 Gene Polymorphisms in Patients with Chronic Plaque-Type Psoriasis: A Case-Control Study. Med Princ Pract 2016;25:155–158.
Mikrani JA and Shrestha A. Clinical and Epidemiological Features of Psoriasis in Patients Visiting Lumbini Medical College. J.Lumbini. 2014 ; 2 : 83-87.
Gao L, Li H, Li K, Shen Z, Liu L, LiC, Zhang Z and Liu Y. Polymorphism of the catechol-O-methyltransferase gene in Han Chinese patients with psoriasis vulgaris. Genetics and Molecular Biology. 2009; 32, 1, 32-36.
Cakmur H, Dervis E. The relationship between quality of life and the severity of psoriasis in Turkey. Eur J Dermatol. 2015;25(2):169-76.
Schafer T. Epidemiology of psoriasis. Dermatology. 2006;212: 327–337.
Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, Body Mass Index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005;125:61–67.
Leyva AM, Real AA, Carrascosa JC, Leyva IM , Sintes RN and Moleon JJ. Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis. An Bras Dermatol. 2015;90(3):338-45.
Gandhi G, Singh Buttar B, Albert L, Hasan O and R.K. Aggarwal R.K. Psoriasis-associated genetic polymorphism in North Indian population in the CCHCR1 gene and in a genomic segment flanking the HLA-C region. Disease Markers . 2011; 31: 361–370.
Siow KY, Safdar NA, Chong KH, Chua KB. A clinical appraisal of patients with psoriasis treated in Seremban General Hospital, Malaysia. Med J Malaysia 2004;59:330-4.
Marino MG, Carboni I, De Felice C, Maurici M, Maccari F, Franco E. Risk factors for psoriasis: A retrospective study on 501 outpatientsí clinical records. Ann Iq 2004;16:753-8.
Ejaz A, Raza N, Iftikhar N , Iftikhar A and Farooq M. Presentation of early onset psoriasis in comparison comparison with late onset psoriasis: A clinical study from Pakistan .Indian J Dermatol Venereol . 2009 ; 75 : 36-40.
Remröd C, Sjöström K and Svensson A . Subjective stress reactivity in psoriasis – a cross sectional study of associated psychological traits. BMC Dermatology .2015; 15:6 :2-8.
Alexander E, Pinto J, Pal G, Kamath N and Kuruvilla M. Disease concomitance in psoriasis: A clinical study of 61 cases. 2001 ; 67 : 2 : 66-68.
Armstrong AW, Voyles SV, Armstrong EJ, et al: Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci 2011; 63: 1–9.
